Skip to main content

and
  1. Article

    Open Access

    Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

    Clinical trials have demonstrated prolonged survival associated with niraparib first-line maintenance (1LM) therapy, compared with placebo, for patients with ovarian cancer (OC). However, data are limited on r...

    Bobbie Rimel, Tirza Areli Calderón Boyle, Sara Burns, Jonathan Lim in Oncology and Therapy (2024)